CORT
Corcept Therapeutics Incorporated · Healthcare · Medical - Pharmaceuticals
动量输入(同类管理人):
持有人广度 -10.0% ·
股份流向 +1.9% ·
净新建仓位 -16.7%
— 公式
集中积累 — 持股数量上升但持有人减少
所有持股数据:仅限已追踪的 13F 管理人,普通股持仓,报告期 Q3 2025
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 115 | +10 | 52.54M | $4.56B | +17 | −6 |
| Q1 2026 | 107 | -4 | 51.80M | $2.09B | +8 | −13 |
| Q4 2025 | 112 | 0 | 56.18M | $1.96B | +1 | — |
| Q3 2025 | 18 | -2 | 41.55M | $3.45B | +1 | −4 |
| Q2 2025 | 18 | +1 | 38.50M | $2.83B | +1 | — |
| Q1 2025 | 14 | +1 | 15.71M | $1.80B | +1 | — |
| Q4 2024 | 13 | 0 | 16.40M | $826.20M | — | — |
| Q3 2024 | 12 | -1 | 13.66M | $632.44M | — | −1 |
| Q2 2024 | 13 | — | 13.78M | $447.82M | — | — |
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (被动) | 12.05M | -3.9% | $1.00B | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | The Vanguard Group ✦ (被动) | 9.54M | -1.5% | $792.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | The Vanguard Group ✦ (被动) | 9.54M | -1.5% | $792.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | The Vanguard Group ✦ (被动) | 9.54M | -1.5% | $792.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | The Vanguard Group ✦ (被动) | 9.54M | -1.5% | $792.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | The Vanguard Group ✦ (被动) | 9.54M | -1.5% | $792.63M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 6.09M | -2.8% | $506.09M | 0.7% | ▼ Trim | 6 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (被动) | 2.97M | +0.1% | $246.87M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 2.20M | +62.3% | $183.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Fidelity (FMR) ✦ | 2.20M | +62.3% | $183.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 29 | Fidelity (FMR) ✦ | 2.20M | +62.3% | $183.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 30 | Fidelity (FMR) ✦ | 2.20M | +62.3% | $183.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 31 | Geode Capital Management ✦ (被动) | 1.93M | +1.0% | $161.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Geode Capital Management ✦ (被动) | 1.93M | +1.0% | $161.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 1.70M | — | $141.26M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | AQR Capital Management ✦ | 1.51M | +546.9% | $125.26M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 1.51M | +546.9% | $125.26M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 1.51M | +546.9% | $125.26M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 1.51M | +546.9% | $125.26M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 1.51M | +546.9% | $125.26M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 48 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Morgan Stanley ✦ | 1.19M | — | $98.65M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | D. E. Shaw & Co. ✦ | 584.10K | -13.2% | $48.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 61 | D. E. Shaw & Co. ✦ | 584.10K | -13.2% | $48.54M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 62 | Goldman Sachs Group ✦ | 389.09K | — | $32.34M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Goldman Sachs Group ✦ | 389.09K | — | $32.34M | 0.0% | n/c | 1 | SEC ↗ |
| 64 | T. Rowe Price ✦ | 383.06K | +160.4% | $31.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 65 | T. Rowe Price ✦ | 383.06K | +160.4% | $31.84M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 66 | Arrowstreet Capital ✦ | 369.39K | -53.2% | $30.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 67 | Bridgewater Associates ✦ | 305.95K | 新增 | $25.43M | 0.1% | New | 1 | SEC ↗ |
| 68 | Millennium Management ✦ | 175.63K | -32.6% | $14.60M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 69 | Citadel Advisors ✦ | 111.59K | -75.0% | $9.27M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 70 | Citadel Advisors ✦ | 111.59K | -75.0% | $9.27M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 71 | Two Sigma Investments ✦ | 42.13K | -30.8% | $3.50M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 72 | Gotham Asset Management ✦ | 17.36K | +0.3% | $1.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Bridgewater Associates | $25.43M | 0.1% |
已清仓
| Norges Bank | $72.05M | 曾为 0.0% |
| Adage Capital Partners | $7.06M | 曾为 0.0% |
| Marshall Wace | $3.39M | 曾为 0.0% |
| Wellington Management | $2.46M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构(SEC结构化数据, Q1 2026): 347 持有人, 79.01M 股份, $2.83B 已申报. 这是与上方被追踪全域数据不同的较早期间,两者从不混用。
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数,而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Director · 4.98K 股 · $585,478
Director · 91.17K 股 · $10.78M
Director · 7.05K 股 · $838,710
Director · 400 股 · $47,855
Officer · 10.00K 股 · $1.16M
Director · 3.05K 股 · $337,341
Director · 4.67K 股 · $520,214
Director · 2.28K 股 · $256,706
Officer · 3.66K 股 · $419,491
Officer · 11.53K 股 · $1.30M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论